Glen Allen, VA, United States of America

Zhi-Hui (Bruce) Lu

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi-Hui (Bruce) Lu. Retrieved from https://idiyas.com/inventor/zhi-hui-bruce-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhi-Hui (Bruce) Lu: Innovator in Heteroaryl Amine Intermediate Compounds

Introduction

Zhi-Hui (Bruce) Lu is a notable inventor based in Glen Allen, VA (US). He has made significant contributions to the field of chemistry, particularly in the development of processes for producing heteroaryl amine intermediate compounds. His work is essential for advancing pharmaceutical research and development.

Latest Patents

Zhi-Hui (Bruce) Lu holds a patent for a process that facilitates the production of a compound of the formula (I). This innovation is crucial for the synthesis of various pharmaceutical compounds, enhancing the efficiency and effectiveness of drug development.

Career Highlights

Currently, Zhi-Hui (Bruce) Lu is employed at Boehringer Ingelheim Pharmaceuticals, Inc. His role at this prominent pharmaceutical company allows him to apply his expertise in chemistry to real-world applications, contributing to the development of new medications.

Collaborations

Throughout his career, Zhi-Hui (Bruce) Lu has collaborated with esteemed colleagues, including Guisheng Li and Jianxiu Liu. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of pharmaceutical chemistry.

Conclusion

Zhi-Hui (Bruce) Lu is a distinguished inventor whose work in heteroaryl amine intermediate compounds has made a significant impact on the pharmaceutical industry. His contributions continue to drive advancements in drug development and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…